Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and PSA in prostate cancer patients receiving radium-223 dichloride therapy.

被引：0
|
作者：
Nakagami, Y. [1 ]
Kano, D. [1 ]
Kusumoto, M. [1 ]
机构：
[1] Natl Canc Ctr, Chiba, Japan
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2015年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P747
引用
收藏
页码：S698 / S699
页数：2
相关论文
共 50 条
  • [31] Radium-223 dichloride treatment for prostate cancer with bone metastases: A symptomatic outcome review of 12 months experience
    Lee, H. H.
    McAddy, N. C.
    O'Sullivan, P.
    Crawley, P.
    Beesley, S.
    Naji, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S214 - S215
  • [32] PROSTATE CANCER Radium-223: a new treatment option for bone-metastatic CRPC
    Grivas, Petros D.
    Keller, Evan T.
    NATURE REVIEWS UROLOGY, 2013, 10 (11) : 630 - 631
  • [33] Bone Scan Index: a prognostic imaging biomarker for high-risk prostate cancer patients receiving primary hormonal therapy
    Reza Kaboteh
    Jan-Erik Damber
    Peter Gjertsson
    Peter Höglund
    Milan Lomsky
    Mattias Ohlsson
    Lars Edenbrandt
    EJNMMI Research, 3
  • [34] Bone Scan Index: a prognostic imaging biomarker for high-risk prostate cancer patients receiving primary hormonal therapy
    Kaboteh, Reza
    Damber, Jan-Erik
    Gjertsson, Peter
    Hoglund, Peter
    Lomsky, Milan
    Ohlsson, Mattias
    Edenbrandt, Lars
    EJNMMI RESEARCH, 2013, 3 : 1 - 6
  • [35] Radium-223 Chloride: Extending Life in Prostate Cancer Patients by Treating Bone Metastases
    Wissing, Michel D.
    van Leeuwen, Fijs W. B.
    van der Pluijm, Gabri
    Gelderblom, Hans
    CLINICAL CANCER RESEARCH, 2013, 19 (21) : 5822 - 5827
  • [36] Radium-223 dichloride in castration-resistant prostate cancer with symptomatic bone metastases: a guide to its use
    Shirley M.
    McCormack P.L.
    Drugs & Therapy Perspectives, 2016, 32 (3) : 98 - 103
  • [37] Radium-223 dichloride for the treatment of bone metastatic castration-resistant prostate cancer: an evaluation of its safety
    Nilsson, Sten
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (07) : 1127 - 1136
  • [38] Radium-223 dichloride bone-targeted alpha particle therapy for hormone-refractory breast cancer metastatic to bone
    Takalkar A.
    Adams S.
    Subbiah V.
    Experimental Hematology & Oncology, 3 (1)
  • [39] Editorial Comment to Bone scan index: A new biomarker of bone metastasis in patients with prostate cancer
    Sakamoto, Shinichi
    INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 (09) : 674 - 674
  • [40] Measurement and radiation control of α-emitting radium-223 in radionuclide therapy for prostate cancer with bone metastases
    Hosono, Makoto
    Hohara, Sin-ya
    Yamanishi, Hirokuni
    Inagaki, Masayo
    Wakabayashi, Genichiro
    Sakaguchi, Kenta
    Hanaoka, Kohei
    Itoh, Tetsuo
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
12345